StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
NIKA

NIKA PHARMACEUTICALS INC.

NIKA OTC Pharmaceutical Preparations EDGAR ↗
$0.51
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$535M
Revenue (TTM)
$0.00
Net income (TTM)
-$76.8K
EPS (TTM)
$0.00
P/E ratio
Dividend yield
Free cash flow
Cash
$1.53K
Total assets
$20.6K
Gross margin
52-week range
$0.20 – $0.96

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-03-31 May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 10-Q/A Quarter ended 2024-06-30 Nov 1, 2024 8-K Changed accountants Oct 16, 2024 8-K Changed accountants Oct 1, 2024 10-Q Quarter ended 2024-06-30 Sep 18, 2024 8-K Completed an acquisition or disposition Aug 27, 2024 10-Q Quarter ended 2024-03-31 May 28, 2024 8-K Completed an acquisition or disposition; Other events May 10, 2024 8-K Completed an acquisition or disposition Apr 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Completed an acquisition or disposition; Amended charter or bylaws Mar 5, 2024 8-K Changed accountants Feb 16, 2024 10-Q Quarter ended 2023-09-30 Oct 31, 2023 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Change in control; Item 5.06 Sep 18, 2023 10-Q Quarter ended 2023-06-30 Aug 21, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 10-K Fiscal year ended 2022-12-31 Apr 10, 2023 8-K Director or officer change Nov 15, 2022 10-Q Quarter ended 2022-09-30 Nov 10, 2022 10-Q/A Quarter ended 2022-06-30 Nov 7, 2022 8-K Changed accountants Nov 1, 2022 10-Q Quarter ended 2022-06-30 Aug 22, 2022 8-K Amended charter or bylaws Aug 22, 2022 10-Q Quarter ended 2022-03-31 May 12, 2022 8-K Completed an acquisition or disposition; Modified rights of security holders; Item 5.06 Apr 12, 2022 8-K Director or officer change Apr 5, 2022 10-K Fiscal year ended 2021-12-31 Mar 3, 2022 10-Q Quarter ended 2021-09-30 Nov 12, 2021 10-Q Quarter ended 2021-06-30 Aug 11, 2021 10-Q Quarter ended 2021-03-31 May 13, 2021 10-K/A Fiscal year ended 2020-12-31 Mar 25, 2021 10-K Fiscal year ended 2020-12-31 Mar 24, 2021
Other filings
144 Apr 16, 2025 4 Mar 19, 2025